Relationship between serum erythropoietin levels and brain injury in preterm infants
CHEN Guang-Fu1, LI Hui-Tao2, HUANG Jin-Jie3, WANG Zhang-Xing4, LI Yun1, YANG Chuan-Zhong2, WU Ben-Qing3, LIU Wen-Lan1, LIU Li-Hui1, KONG Qi1, LIU Rong-Tian1
Department of Pediatrics, Shenzhen Second People's Hospital/First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, China
Abstract：Objective To study the relationship between the levels of erythropoietin (EPO) in serum and brain injury in preterm infants. Methods Three hundred and four preterm infants (gestational age: 28-34 weeks) born between October 2014 and September 2015 were enrolled in this study. Brain injury was diagnosed using cerebral ultrasound and MRI. The levels of EPO, S100 protein, neuron-specific enolase (NSE) and myelin basic protein (MBP) in serum were detected using ELISA. To compare the incidence of brain injury in different serum EPO levels in preterm infants, and the relationship between brain injury and serum EPO levels was analyzed. Results The incidence rate of brain injury in preterm infants was 41.1% (125/304). The incidence rate of brain injury in the low EPO level group was significantly higher than that in the middle-high EPO level groups (P P P Conclusions There is a higher incidence rate of brain injury in preterm infants with lower serum EPO levels. The serum EPO levels may be correlated with brain injury in preterm infants.
Juul SE, Ferriero DM. Pharmacologic neuroprotective strategies in neonatal brain injury[J]. Clin Perinatol, 2014, 41(1): 119-131.
[3]
Mazur M, Miller RH, Robinson S. Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury[J]. J Neurosurg Pediatr, 2010, 6(3): 206-221.
[4]
Sirén AL, Fasshauer T, Bartels C, et al. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system[J]. Neurotherapeutics, 2009, 6(1): 108-127.
Panigrahy A, Wisnowski JL, Furtado A, et al. Neuroimaging biomarkers of preterm brain injury: toward developing the preterm connectome[J]. Pediatr Radiol, 2012, 42(Suppl 1): S33-S61.
[12]
Jantzie LL, Miller RH, Robinson S. Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury[J]. Pediatr Res, 2013, 74(6): 658-667.
Marret S, Marchand-Martin L, Picaud JC, et al. Brain injury in very preterm children and neurosensory and cognitive disabilities during childhood: the EPIPAGE cohort study[J]. PLoS One, 2013, 8(5): e62683.
[15]
Wu YW, Gonzalez FF. Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?[J]. Dev Med Child Neurol, 2015, 57(Suppl 3): 34-39.
[16]
Traudt CM, Juul SE. Erythropoietin as a neuroprotectant for neonatal brain injury: animal models[J]. Methods Mol Biol, 2013, 982: 113-126.
[17]
Leuchter RH, Gui L, Poncet A, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age[J]. JAMA, 2014, 312(8): 817-824.
[18]
Ma W, Kantarjian H, Zhang K, et al. Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome[J]. BMC Med Genet, 2010, 11: 163.
[19]
Douglas-Escobar M, Weiss MD. Biomarkers of brain injury in the premature infant[J]. Front Neurol, 2013, 3: 185.
[20]
Hergenroeder GW, Redell JB, Moore AN, et al. Biomarkers in the clinical diagnosis and management of traumatic brain injury[J]. Mol Diagn Ther, 2008, 12(6): 345-358.
[21]
Rees S, Hale N, De Matteo R, et al. Erythropoietin is neuroprotective in a preterm ovine model of endotoxin-induced brain injury[J]. J Neuropathol Exp Neurol, 2010, 69(3): 306-319.
[22]
Lemus-Varela ML, Flores-Soto ME, Cervantes-Munguía R, et al. Expression of HIF-1 alpha, VEGF and EPO in peripheral blood from patients with two cardiac abnormalities associated with hypoxia[J]. Clin Biochem, 2010, 43: 234-239.
[23]
Alexander ML, Hill CA, Rosenkrantz TS, et al. Evaluation of the therapeutic benefit of delayed administration of erythropoietin following early hypoxic-ischemic injury in rodents[J]. Dev Neurosci, 2012, 34(6): 515-524.
[24]
Yu Z, Tang L, Chen L, et al. Erythropoietin reduces brain injury after intracerebral hemorrhagic stroke in rats[J]. Mol Med Rep, 2013, 8(5): 1315-1322.
[25]
Barton SK, Tolcos M, Miller SL, et al. Ventilation-Induced Brain Injury in Preterm Neonates: A Review of Potential Therapies[J]. Neonatology, 2016, 110(2): 155-162.
